We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Genes Found That Extend Lifespan

By Biotechdaily staff writers
Posted on 13 Oct 2005
Scientists have found new genes associated with lifespan extension in yeast. More...


Significantly reducing calorie intake, or caloric restriction, is known to extend the lifespan of organisms including yeast, worms, and rodents. Earlier studies tied a gene called Sir2 with lifespan extension caused by caloric restriction, but yeast and worms that lack Sir2 also live longer when put on a restricted diet, demonstrating that some other genes must be at work.

Researchers led by Dr. David Sinclair at Harvard Medical School (Boston, MA, USA) and Dr. Su-Ju Lin from the University of California, Davis, Center for Genetics and Development and Section of Microbiology (UC Davis; USA) screened for other life-extending genes in yeast. They discovered a gene called Hst2 that accounts for most of the discrepancy.

Deleting Hst2 and Sir2 blocked most of the beneficial effect of caloric restriction. When Hst2 was overexpressed, so that the gene was more active than normal, the yeast lived longer than normal. A third gene, Hst1, seems to function when both Sir2 and Hst2 are missing. Sir2 and the newly found Hst genes account for all of the life-extending effects of caloric restriction in yeast, according to Dr. Lin.

In yeast, the effects of aging seem to be caused by an accumulation of toxic circular DNA molecules that mistakenly get copied out of ribosomal DNA, an unstable region of the yeast genome that contains hundreds of repeated sequences. The investigators showed that caloric restriction dramatically reduces recombination of ribosomal DNA, and that deleting Hst2 and Sir2 stops this process.

Very similar genes are found in broadly diverse animals including worms, flies, and rodents. However, the targets of these genes are likely to be different, as the toxic DNA circles have not been identified in more sophisticated organisms, according to Dr. Lin.

The study was published in the September 16, 2005, issue of the journal Science.






Related Links:
Harvard Medical School
University of California, Davis

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.